Skip to Content

Stephen G. Patterson, MD

photo of Dr. Stephen Patterson
Hematology and Oncology

Focus Areas
Hematology / Oncology

Notable Work Experience
Chief Medical Information Officer, Medical Oncology Fellowship Program Director - Nevada Cancer Institute - Las Vegas, NV (2010)
Chief Medical Information Officer, H. Lee Moffitt Cancer Center - Tampa, FL (2005-2010)

American Board of Internal Medicine
American Board of Internal Medicine - Medical Oncology

Fellowship, Medical Oncology/Hematology - University of South Florida - Tampa, FL (1995-1998)
Residency, Internal Medicine - University of South Florida - Tampa, FL (1992-1995)

Higher Education
University of South Florida Leadership Institute - Tampa, FL (2010)
University of South Florida - M.D. - Tampa, FL (1992)
University of Notre Dame - B.S. - Notre Dame, IN (1988)

Professional Associations
American Medical Informatics Society
Healthcare Information and Management Systems Society
Association of Medical Directors of Information Systems
American Society of Clinical Oncology
Equestrian Order of the Holy Sepulcher

A Multicenter, Open Label, Randomized Phase III trial comparing Immediate Adjuvant Hormonal Therapy (Eligard-leuprolide acetate) In combination With TAXOTERE (docetaxel) Administered Every Three Weeks Versus hormonal Therapy Alone Versus Deferred Therapy.

A Randomized Multicenter Phase II Trial of Patupilone (EPO0906) Plus Prednisone versus Docetaxel (Taxotere) Plus Prednisone in Patients with Metastatic Hormone Refractory Prostate Cancer

An exploratory Phase II, Multicenter, Open-Label Trial Evaluating the Activity and Tolerability of FK228 in Androgen Independent Metastatic Prostate Cancer Patients with Rising PSA

Correlation of Fatigue and Testosterone Levels in Castrated Prostate Cancer Patients

A Multicenter, Single-Arm, Open-Label Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide (Revlimid) in Subjects with Androgen Independent Prostate Cancer

Phase III Intermittent Androgen Deprivation in Patients with Stage
D2 Prostate Cancer

A Phase II Trial of Weekly Taxotere and Dexamethasone in Hormone-Insensitive D2 (D1) Prostate cancer and a Pilot Study of Taxotere Pharmacokinetics

A Phase II Trial of Daily, Oral Thalidomide and Dexamethasone in Patients with Stage D hormone-Insensitive, Chemotherapy-Insensitive Prostate Cancer.

Impact of LHRH Agonists on Cognitive Function in Prostate Cancer Patients

LHRH Agonist therapy and Cognitive Functioning in Men with Prostate Cancer.

Identification of Gene Expression Differences between Chemotherapy Naïve and Chemotherapy Exposed Clones of Established Prostate Cancer Cell Lines.

LHRH Agonist therapy and Cognitive Functioning in Men with Prostate Cancer.

Kawachi MH, Bahnson RR, Barry M, Busby JE, Carroll PR, Carter HB, Catalona WJ, Cookson MS, Epstein JI, Giri VN, Hemstreet GP 3rd, Howe RJ, Lange PH, Lilja H, Loughlin KR, Mohler J, Moul J, Nadler RB, Patterson SG, Presti JC, Stroup AM, Wake R, Wei JT. NCCN clinical practice guidelines in oncology: prostate cancer early detection. J Natl Compr Canc Netw. 2010 Feb;8(2):240-62.

Molife, L.R., Attard, G., Fong, P.C., Karavasilis, V., Reid, A.H.M., Patterson, S., Riggs Jr, C.E., Higano, C., Stadler, W.M., McCulloch, W., Dearnaley, D., Parker, C., de Bono, J.S.: Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC). Ann Oncol. 2010 Jan;21(1):109-13.

Jim, HS, Small BJ, Patterson S, Salup R, Jacobsen PB. Cognitive impairment in men treated with leutinizing hormone releasing hormone agonists for prostate cancer: a controlled comparison. Support Care Cancer. 2009 Apr 3.

Ulloa Winters, E., Salup R., Patterson, S.G. and Jacobsen, P.B.: Relationship between Hot Flashes and Distress in Men Receiving Androgen Deprivation Therapy for Prostate Cancer. Psycho-Oncology 18:598-605 (2009) Published online 22 October 2008 in Wiley Inter-Science. DOI:10.1002/pon.1427.

Patterson, S.G., Winters, E., Kish, J.A., Agresta, S., Garber, D., Jacobsen, P.B. Relationship of Hot Flashes to Fatigue in Men Receiving Androgen Deprivation Therapy for Prostate Cancer. European Urology. Submitted July 2007.

Patterson, S.G., French, S., Bria: W.F. Clinical Decision support: Lessons from the Field on the Integration of Medical Intelligence and Information Technology. Healthcare Technology, 4: 66-68, 2007.

Alekshun, T.J., Patterson, S.G.  : Management of Hot Flashes in Men with Prostate Cancer with Androgen Deprivation Therapy. Supportive Cancer Therapy, Oct Vol.4, No.1, pp. 30-37, 2006.

Park, J., Chen, L., Ratnashinge, L., Sellers, T., Tanner, J., Lee, J., Dossett, N., Lang, N., Kadlubar, F., Ambrosome, C., Zachariah, B., Heysek, R., Patterson, S., Powsang, J.: Deletion Polymorphism of UDP-Glucuronosyltransferase 2B17 and Risk of Prostate Cancer in African American and Caucasian Men. Cancer Epidemiol Biomarkers Prev 2006; 15(8). August 2006.

Ho, V.Q., Wetzstein, G.A., Patterson, S.G., Bradbury, R.: Abbreviated Rasburicase dosing for the prevention and treatment of Hyperuricemia in adults at risk for Tumor Lysis Syndrome. Supportive Cancer Therapy, 3(3): 1787-182, 2006.

Patterson, S.G., Wei, S., Chen, X., Sallman, D.A., Gilvary, D.I., Zhong, B., Pow-Sang, J., Yeatman, T., Djeu, JY: Novel Role of Stat1 in the Development of Docetaxel Resistance in Prostate Tumor Cells. Oncogene, May 1, pp. 1-10, 2006.

Diaz, Michael, Patterson, S.G.: Management of Androgen-Independent Prostate Cancer-Cancer Control, Vol.11, No.6, pgs 364-373, November/December 2004.

Park J, Chen L, Shade K, Lazarus P, Seigne J, Patterson S, Helal M, Powsang J. Asp85tyr polymorphism in the udp-glucuronosyltransferase (UGT) 2B15 gene and the risk of prostate cancer. J Urol. 2004 Jun;171(6Pt1):2484-8.

Patterson, S.G., Davis Christine, Schmitzer Jessica, Foster Elissa, Baglia Jay, Balducci Lodovico, Ellis Carolyn: Spiritual Dimension of Cancer Care. Journal of Cancer Integrative Medicine, Vol.2 No.2, Spring 2004.

Patterson, S., Balducci, L. The Book of Job: A 2,500 year-old Current Guide to the practice of Oncology: The Nexus of Medicine and Spirituality. Journal of Cancer Education, Vol.17, No. 4, Pgs 237-241, Winter 2002.

Patterson, S.G., Balducci, L.B., Pow-Sang, J.M.: Controversies Surrounding Androgen Deprivation for Prostate Cancer. Cancer Control, Vol. 9, No.4, July/August, Pgs. 315-325, 2002.

Greene, G., Patterson, S. G., Warner, E.: Ingestion of Angel’s Trumpet An increasingly common source of toxicity.  Southern Medical Journal, Volume 89, Number 4, Pgs. 365-369, 1996.

Helfet, D.L., Koval, K.J., Hissa, E.A., Patterson, S.G., DiPasquale, T., Sanders, R.:  Intraoperative somatosensory evoked potential monitoring during acute pelvic fracture surgery.  Journal of Orthopedic Trauma, Volume 9, Number 1, Pgs. 28-34, 1993.


be Confirmed , FL 00000

My Health Patient Portal


Receive monthly, personalized Health-e-news from Holy Cross Hospital.

Please verify insurance coverage with the Physician Office.